Liver, Kidney and Pancreas Transplant Research and Publications
Find a research trial at Baylor.Peer-Reviewed Scientific Papers
Scholz T, Solberg R, Okkenhaug C, Videm V, Gallimore MJ, Mathisen O, Mollnes TE, Bergan A, Soreide O, Klintmalm GB, and Aasen AO. The significance of heparin-coated veno-venous bypass circuits in liver transplantation. Perfusion 17:45-50, 2002.
Molmenti EP, Roodhouse TW, Molmenti H, Jaisway K, Jung GJ, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA, and Klintmalm GB. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Annals of Surgery 235(2): 292-296, 2002.
Molmenti EP, Levy MF, Molmenti H, Casey D, Fasola CG, Hamilton WM, Ghapjoong J, Marubashi S, Gogel BM, Goldstein RM, Gonwa TA, and Klintmalm GB. Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transplantation 8(2): 160-163, 2002.
Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, Fasola CG, Gonwa TA, Jennings LW, Brooks BK, and Klintmalm GB. DeNovo tumors after liver transplantation: a single-institution experience. Liver Transplantation 8(3): 285-291, 2002.
Gonwa TA, Mai ML, Melton LB, Levy MF, Goldstein RM, and Klintmalm GB. Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: Use of low dose tacrolimus therapy with postoperative administration of anti-CD25 monoclonal antibody. Clin Transplant 16:144-149, 2002.
Molmenti EP, Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, Hoover TC, Jung GJ, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Gonwa TA, and Klintmalm GB. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transplantation 8(6): 519-526, 2002.
Molmenti EP, Wilkinson K, Molmenti H, Roden JS, Squires RH, Fasola CG, Tomlinson G, Nagata DE, D'Amico L, Lopez MJ, Savino LM, Marubashi S, Sanchez ES, Goldstein RM, Levy MF, Andrews W, Andersen JA, and Klintmalm GB. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. American Journal of Transplantation 2: 535-538, 2002.
Fasola CG and Klintmalm GB. Letter to the Editor: Hepatitis C and mycopholate mofetil - a clarification. Liver Transplantation 8(4):411-413, 2002.
Molmenti EP and Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the international tumor registry. Liver Transplantation 8(9):736-748, 2002
Melear JM, Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, Klintmalm GB, and Stone MJ. Hematologic aspects of liver transplantation for budd-chiari syndrome with special reference to myeloproliferative disorders. Transplantation 74(8):1090-1095, 2002.
Molmenti EP, Smith DM, Molmenti H, Fasola CG, Aguanno JJ, Savino AC, Peterson TS, Barshes V, Levy MF, Goldstein RM, and Klintmalm GB. Unusually high incidence of positive HTLV I/II Results among young female organ donors in the peripartum period. Digestive Diseases and Sciences 47 (11):2383-2385, 2002.
Books
Molmenti EP and Klintmalm GB. Atlas of Liver Transplantation. W.B. Saunders Company, 2002.
Busuttil RW and Klintmalm GB, (eds). Transplantation of the Liver. W.B. Saunders Company, 1996.
Klintmalm GB and Levy MF, (eds). Organ Procurement and Preservation. Landes Bioscience, 1999.
Published Abstracts
First MR, West J, Aeder M, Danovitch G, Klintmalm G, Gorman K, Gordon J and Spinola K. Differences in patient and healthcare provider perceptions of immunosuppression-induced physical side effects. American Journal of Transplantation 2 (Suppl 3): 404, 2002.
Onaca NN, Levy MF, Thomas MJ, Sanchez EQ, Brooks BK, Chinnakotla S, Fasola CG, Weinstein JS, Murray N, Goldstein RM, and Klintmalm GB: The pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. American Journal of Transplantation 2 (Suppl 3): 252, 2002.
Onaca N, Netto GJ, Morkowski J, Katabi N, Levy MF, Thomas MJ, Sanchez EQ, Weinstein JS, Murray N, Goldstein RM, and Klintmalm GB: Influence of steatosis in the liver allograft in the incidence of recurrent hepatitis C after liver transplantation. American Journal of Transplantation 2 (Suppl 3): 429, 2002.
Sanchez EQ, Gonwa TA, Levy MF, Fasola CG, Goldstein RM, Chinnakotla S, Melton LB, Hays SR, Onaca N, Thomas M, and Klintmalm GB: Perioperative predictors of renal replacement therapy after orthotopic liver transplantation: Implications for MELD scoring. American Journal of Transplantation 2 (Suppl 3): 299, 2002.
Fasola CG, Netto GJ, Christense LL, Weinstein J, Murray N, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB: Evoluton of hepatitis C recurrence post liver transplantation in the last ten years: More aggressive recurrence in recent years? American Journal of Transplantation 2 (Suppl 3): 139, 2002.
Fasola CG, Netto G, Christensen L, Rakela J, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB: The importance of HCV-RNA level determinations in early detection of aggressive hepatitis C recurrence post liver transplantation: The third month gap. American Journal of Transplantation 2 (Suppl 3): 164, 2002.
Fasola CG, Netto G, Christensen LL, Rakela J, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB: Lower incidences of early hepatitis C-RNA levels and HCV recurrence post liver transplantation in patients induced with mycophenolate mofetil: A high-dose benefit. American Journal of Transplantation 2 (Suppl 3): 196, 2002.
Presentations
First MR, Peters T, West J, Aeder M, Danovitch G, Klintmalm G, Gorman K, Gordon J and Spinola K. Differences in patient and heathcare provider perceptions of immunosuppression-induced physical side effects. American Transplant Congress, Washington, DC, April/May 2002. (poster presentation)
Onaca NN, Levy MF, Thomas MJ, Sanchez EQ, Brooks BK, Chinnakotla S, Fasola CG, Weinstein JS, Murray N, Goldstein RM, and Klintmalm GB: The pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. American Transplant Congress, Washington, D.C., April/May 2002 (oral presentation)
Onaca N, Netto GJ, Morkowski J, Katabi N, Levy MF, Thomas MJ, Sanchez EQ, Weinstein JS, Murray N, Goldstein RM, and Klintmalm GB: Influence of steatosis in the liver allograft in the incidence of recurrent hepatitis C after liver transplantation. American Transplant Congress, Washington, D.C., April/May 2002 (poster presentation)
Sanchez EQ, Gonwa TA, Levy MF, Fasola CG, Goldstein RM, Chinnakotla S, Melton LB, Hays SR, Onaca N, Thomas M, and Klintmalm GB: Perioperative predictors of renal replacement therapy after orthotopic liver transplantation: Implications for MELD scoring. American Transplant Congress, Washington, D.C., April/May 2002 (poster presentation)
Fasola CG, Netto GJ, Christense LL, Weinstein J, Murray N, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB: Evoluton of hepatitis C recurrence post liver transplantation in the last ten years: More aggressive recurrence in recent years? American Transplant Congress, Washington, D.C., April/May 2002 (oral presentation)
Fasola CG, Netto G, Christensen L, Rakela J, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB: The importance of HCV-RNA level determinations in early detection of aggressive hepatitis C recurrence post liver transplantation: The third month gap. American Transplant Congress, Washington, D.C., April/May 2002 (oral presentation)
Fasola CG, Netto G, Christensen LL, Rakela J, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB: Lower incidences of early hepatitis C-RNA levels and HCV recurrence post liver transplantation in patients induced with mycophenolate mofetil: A high-dose benefit. American Transplant Congress, Washington, D.C., April/May 2002 (poster presentation)
Klintmalm GB and Molmenti EP. Hepatocellular carcinoma in 790 patients. A report from the international tumor registry. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (oral presentation)
Sanchez EQ, Gonwa TA, Levy MF, Fasola CG, Goldstein RM, Chinnakotla S, Melton LB, Hays SR, Onaca N, Thomas M, and Klintmalm GB. Perioperative predictors of renal replacement therapy after orthotopic liver transplantation: implications for meld scoring. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (poster presentation)
Fasola CG, Netto G, Christensen LL, Rakela J, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB. Lower incidences of early hepatitis C (HCV) - RNA levels and HCV recurrence (R) post liver transplantation (OLT) in patients induced with mycophenolate mofetil (MMF): a high-dose benefit. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (poster presentation)
Fasola CG, Netto G, Christensen L, Rakela J, Thomas M, Onaca N, Sanchez E, Chinnakotla S, Levy M, Goldstein R, and Klintmalm G. Evolution of hepatitis C recurrence (HCVR) post liver transplantation (OLT) in the last ten years: more aggressive recurrence in recent years? International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (poster presentation)
Fasola CG, Netto G, Christensen LL, Rakela J, Thomas M, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB. The importance of HCV-RNa level determinations in early detection of aggressive hepatitis C recurrence (HCVR) post liver transplantation (OLT): the third month gap. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (poster presentation)
Sullivan SO, Jennings LW, Goldstein RM, and Klintmalm GB. The international tumor registry going web. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (poster presentation)
Molmenti EP, Molmenti H, Weinstein J, Fasola CG, Elliott EE, Orr D, Blum J, Savino D, Goldstein RM, Levy MF, and Klintmalm GB. Association between liver transplantation, breast cancer, and ovarian cancer. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (poster presentation)
Onaca NN, Levy MF, Thomas MJ, Sanchez EQ, Brooks BB, Chinnakotla S, Fasola CG, Weinstein JW, Murray NG, Goldstein RM, and Klintmalm GB. A correlation between pre-transplant meld score and mortality in the first two years posttransplant. International Liver Transplantation Society 2002 Annual Meeting, Chicago, IL, June 13-15, 2002 (oral presentation)
Klintmalm GB. Impact of age on donor selection and recipient outcome. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002 (oral presentation)
Klintmalm GB and Molmenti EP. Hepatocellular carcinoma in 790 patients. A report from the international tumor registry. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002 (oral presentation)
Fasola CG, Netto G, Christensen L, Rakela J, Thomas M, Onaca N, Sanchez E, Chinnakotla S, Levy M, Goldstein R, and Klintmalm G. Lower incidences of early hepatitis C (HCV)-RNA levels and HCV recurrence (R) post liver transplantation (OLT) in patients induced with mycophenolate mofetil (MMF): a high-dose benefit. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002 (oral presentation)
Fasola CG, Netto GJ, Christensen LL, Rakela J, Thomas MJ, Onaca N, Sanchez EQ, Chinnakotla S, Levy MF, Goldstein RM, and Klintmalm GB. The importance of HCV-RNA level determinations in early detection of aggressive hepatitis C recurrence (HCVR) post liver transplantation (OLT): the third month gap. XIX International Congress of The Transplantation Society, Miami, FL, August 25-30, 2002 (poster presentation).